+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
Bleeding Disorders Treatment Market Report 2025 - Product Thumbnail Image

Bleeding Disorders Treatment Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Leukocyte Adhesion Deficiency Management Market Report 2025 - Product Thumbnail Image

Leukocyte Adhesion Deficiency Management Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Nephrology Drugs Market Report 2025 - Product Thumbnail Image

Nephrology Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Albumin Excipient Market Report 2025 - Product Thumbnail Image

Albumin Excipient Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
Hidradenitis Suppurativa - Pipeline Insight, 2025 - Product Thumbnail Image

Hidradenitis Suppurativa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
Loading Indicator